---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-011646"
form_type: "8-K"
ticker: "JANX"
cik: "0001817713"
company_name: "Janux Therapeutics, Inc."
filed_at: "2022-06-15T23:59:59+00:00"
generated_at: "2026-06-25T01:41:13.568084+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Janux Therapeutics stockholders elect three Class I directors, ratify auditor at 2022 annual meeting

## Summary
- David Campbell, Ron Barrett, and Stefan Heller elected as Class I directors with 33.9M, 34.7M, and 33.9M votes for, respectively.
- Ernst & Young LLP ratified as independent auditor for FY2022 with 37.85M votes for, 3 against, 244 abstentions.
- Broker non-votes of 2,998,529 on all director elections; none on auditor ratification.
- Total outstanding shares as of record date April 18, 2022: 41,629,367.

## SEC filing metadata
- accession: 0000950170-22-011646
- form_type: 8-K
- ticker: JANX
- cik: 0001817713
- company_name: Janux Therapeutics, Inc.
- filed_at: 2022-06-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817713/000095017022011646/0000950170-22-011646-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817713/000095017022011646/janx-20220614.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-011646
- JSON: https://secwatch.observer/filing/0000950170-22-011646.json
- Plain text: https://secwatch.observer/filing/0000950170-22-011646.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.